Building on a rich tradition of hosting the event in Zürich, the 2024 edition of the conference is headed to a new location in Muttenz, taking advantage of networking and technology strengths that Basel, Switzerland’s pharmaceutical capital, has to offer. The scientific excellence and diverse program that attendees appreciate will remain unchanged.
Session topics for the 2024 edition will include:
- mRNA therapeutics
- Immune disease interfaces
- Biosensing and diagnostics
- Mechanobiology and mechanoimmunology
- Biomaterials
- Bioprinting and biofabrication
